Atovaquone

25.00 - 50.00 INR

Get a Price/Quote

Product Details:

Molecular Formula C22H19ClO3
Storage Room Temperature
Molecular Weight 366.837 Grams (g)
Medicine Name Atovaquone
Type Pharmaceutical Intermediates
Grade Medicine Grade
Purity(%) 98%
Supply Ability : 1000 Kilograms Per Day
Click to view more
Share Your Product:

Ask A Question Send Inquiry

Price And Quantity

Price Range 25.00 - 50.00 INR
Minimum Order Quantity 25 Kilograms

Product Specifications

Physical Form Powder
Molecular Formula C22H19ClO3
Purity(%) 98%
Type Pharmaceutical Intermediates
Molecular Weight 366.837 Grams (g)
Storage Room Temperature
Medicine Name Atovaquone
Grade Medicine Grade

Trade Information

Payment Terms Cash in Advance (CID), Cash Advance (CA)
Supply Ability 1000 Kilograms Per Day
Delivery Time 7 Days
Main Export Market(s) Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

Product Description

It is a hydroxynaphthoquinone that has antimicrobial activity and is being used in antimalarial protocols. Our qualitative approach regarding the domain enabled us to merge as a trusted organization engaged in offering Atovaquone. This drug is used to prevent or treat a serious lung infection called Pneumocystis pneumonia. This medication helps to stop infection symptoms such as fever, cough, tiredness, and shortness of breath. Atovaquone is a highly lipophilic drug that closely resembles the structure ubiquinone. This drug can act by selectively affecting mitochondrial electron transport and parallel processes such as ATP and pyrimidine biosynthesis.

Features:

Product Name : Atovaquone
Chemical Names : Mepron; Wellvone; Acuvel; Malarone Pediatric; Atovaquone & Interleukin 12
Molecular Formula : C₂₂H₁₉ClO₃
Molecular Weight : 366.841 g/mol
IUPAC Name : 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione
CAS Number : 94015-53-9
Color : Crystals from acetonitrile
Melting Point : 216-219 Â°C
Solubility : Practically insoluble in water

Drug Indication: For the treatment or prevention of Pneumocystis carinii pneumonia in patients who are intolerant to trimethoprim-sulfamethoxazole (TMP-SMX).